Immunohistochemical analysis of radiation-induced non-healing dermal wounds of the head and neck

In Vivo

Volumn 19, Issue 2, 2005, Pages 343-350

  Riedel, Frank ^a   Philipp, Katrin ^b   Sadick, Haneen ^a   Goessler, Ullrich ^a   Hörmann, Karl ^a   Verse, Thomas ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Angiogenesis; Chronic wound; MMP; Radiation; TIMP

Indexed keywords

ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; GELATINASE A; GELATINASE B; INTERLEUKIN 8; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ARTICLE; CANCER RADIOTHERAPY; CAPILLARY DENSITY; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HEAD AND NECK DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROVASCULATURE; PROTEIN EXPRESSION; PROTEIN FUNCTION; RADIATION INJURY; SKIN INJURY; WOUND HEALING IMPAIRMENT;

EID: 16344367726     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Habel DW: Surgical complications in irradiated patients. Arch Otolaryngol 82: 382-386, 1965.
2. Hom DB, Adams G, Koreis M and Maisel R: Choosing the optimal wound dressing for irradiated soft tissue wounds. Otolaryngol Head Neck Surg 121: 591-598, 1999.
3. Singer AJ and Clark RA: Cutaneous wound healing. N Engl J Med 341: 738-746, 1999.
4. Falanga V: Chronic wounds: pathophysiologic and experimental consideration. J Invest Dermatol 100: 721-725, 1993.
5. Wall SJ, Bevan D, Thomas DW, Harding KG, Edwards DR and Murphy G: Differential expression of matrix metalloproteinases during impaired wound healing of the diabetes mouse. J Invest Dermatol 119 91-98, 2002.
6. Arnold F and West DC: Angiogenesis in wound healing. Pharmacol Ther 52: 407-422, 1991.
7. Thompson WD, Harvey JA, Kazmi MA and Stout AJ: Fibrinolysis and angiogenesis in wound healing. J Pathol 165: 311-318, 1991.
8. Brem H, Balledux J, Bloom T, Kerstein MD and Hollier L: Healing of diabetic foot ulcers and pressure ulcers with human skin equivalent, a new paradigm in wound healing. Arch Surg 135: 627-634, 2000.
9. Stadelmann WK, Digenis AG and Tobin GR: Impediments to wound healing. Am J Surg 176: 39S-47S, 1998.
10. Flamme, von Reutern M, Drexler HC, Syed-Ali S and Risau W: Overexpression of vascular endothelial growth factor in the avian embryo induces hypervascularization and increased vascular permeability without alterations of embryonic pattern formation. Dev Biol 171: 399-414, 1995.
11. Hippenstiel S, Krull M, Ikemann A, Risau W, Clauss M and Suttorp N: VEGF induces hyperpermeability by a direct action on endothelial cells. Am J Physiol 274: L678-L684, 1998.
12. Nissen NN, Polverini PJ, Koch AE, Volin MV, Gamelli RL and DiPietro LA: Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol 152: 1445-1452, 1998.
13. Ravanti L and Kahari VM: Matrix metalloproteinases in wound repair. Int J Mol Med 6: 391-407, 2000.
14. Grillo HC and Gross J: Collagenolytic activity during mammalian wound repair. Dev Biol 15: 300-317, 1967.
15. Herouy Y: Matrix metalloproteinases in skin pathology. Int J Mol Med 7: 3-12, 2001.
16. Salo T, Makela M, Kylmaniemi M, Autio-Harmainen H and Larjava H: Expression of matrix metalloproteinase-2 and -9 during early human wound healing. Lab Invest 70: 176-182, 1994.
17. Parks WC: The production, role, and regulation of matrix metalloproteinases in the healing epidermis. Wounds 7: 23A-37A, 1995.
18. Petri JB, König S, Haupt B, Haustein UF and Herrmann K: Molecular analysis of different phases in human wound healing. Exp Dermatol 6: 133-139, 1997.
19. Visse R and Nagase H: Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92: 827-839, 2003.
20. Gomez DE, Alonso DF, Yoshiji H and Thorgeirsson UP: Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 74: 111-122, 1997.
21. Kerkela E and Saarialho-Kere U: Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer. Exp Dermatol 12: 109-125, 2003.
22. Gomis-Ruth FX, Maskos K, Betz M, Bergner A, Huber R, Suzuki K, Yoshida N, Nagase H, Brew K, Bourenkov GP, Bartunik H and Bode W: Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature 389: 77-81, 1997.
23. Miller SH and Rudolph R: Healing in the irradiated wound. Clin Plast Surg 17: 503-508, 1990.
24. Stearner SP and Christian EJ: Late effects of ionizing radiations in the chicken: survival, body weight, and pathology. Radiat Res 52: 179-196, 1972.
25. Aitasalo K and Aro H: Irradiation-induced hypoxia in bones and soft tissues: an experimental study. Plast Reconstr Surg 77: 256-267, 1986.
26. Bernatchez PN, Soker S and Sirois MG: Vascular endothelial growth factor effect on endothelial cell proliferation, migration, and platelet-activating factor synthesis is Flk-1-dependent. J Biol Chem 274: 31047-31054, 1999.
27. Steed DL: The role of growth factors in wound healing. Surg Clin North Am 77: 575-586, 1997.
28. Hockel M, Schlenger K, Doctrow S, Kissel T and Vaupel P: Therapeutic angiogenesis. Arch Surg 128: 423-429, 1993.
29. Uhl E, Barker JH, Bondar I, Galla TJ, Leiderer R, Lehr HA and Messmer K: Basic fibroblast growth factor accelerates wound healing in chronically ischaemic tissue. Br J Surg 80: 977-980, 1993.
30. Xia YP, Zhao Y, Marcus J, Jimenez PA, Ruben SM, Moore PA, Khan F and Mustoe TA: Effects of keratinocyte growth factor-2 (KGF-2) on wound healing in an ischaemia-impaired rabbit ear model and on scar formation. J Pathol 188: 431-438, 1999.
31. Yager DR and Nwomeh BC: The proteolytic environment of chronic wounds. Wound Rep Regen 7: 433-441, 1999.
32. Bennett NT and Schultz GS: Growth factors and wound healing: biochemical properties of growth factors and their receptors, Am J Surg 165: 728-737, 1993.
33. Kähäri VM and Saarialho-Kere U: Matrix metalloproteinases in skin. Exp Dermatol 6: 199-213, 1997.
34. Soo C, Shaw WW, Zhang X, Longaker MT, Howard EW and Ting K: Differential expression of matrix metalloproteinases and their tissue-derived inhibitors in cutaneous wound repair. Plast Reconstr Surg 105: 638-647, 2000.
35. Baker EA and Leaper DJ: Proteinases, their inhibitors, and cytokine profiles in acute wound fluid. Wound Rep Regen 8: 392-398, 2000.
36. Weckroth M, Vaheri A, Lauharanta J, Sorsa T and Konttinen YT: Matrix metalloproteinases, gelatinase and collagenase, in chronic leg ulcers. J Invest Dermatol 106: 1119-1124, 1996.
37. Mast BA and Schultz GS: interactions of cytokines, growth factors, and proteases in acute and chronic wounds. Wound Rep Regen 4 411-420, 1996.
38. Trengove NJ, Stacey MC, MacAuley S, Bennett N, Gibson J, Burslem F, Murphy G and Schultz G: Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Rep Regen 7: 442-452, 1999.
39. Vaalamo M, Weckroth M, Puolakkainen P, Kere J, Saarinen P, Lauharanta J and Saarialho-Kere UK: Patterns of matrix metalloproteinase and TIMP-1 expression in chronic and normally healing human cutaneous wounds. Br J Dermatol 135: 52-5, 1996.
40. Saarialho-Kere UK: Patterns of matrix metalloproteinase and TIMP expression in chronic ulcers. Arch Dermatol Res 290 Suppl: S47-54; 1998.
41. Saito S, Trovato MJ, You R, Lal BK, Fasehun F, Padberg FT Jr, Hobson RW 2nd, Duran WN and Pappas PJ: Role of matrix metalloproteinases 1, 2, and 9 and tissue inhibitor of matrix metalloproteinase-1 in chronic venous insufficiency. J Vasc Surg 34: 930-938, 2001.
42. Williams RL and Armstrong DG: Wound healing. New modalities for a new millennium. Clin Podiatr Med Surg 15: 117-128, 1998.
43. Philipp K, Riedel F, Sauerbier M, Hörmann K and Germann G: Targeting TGF-beta in human keratinocytes and its potential role in wound healing. Int J Mol Med 14: 589-593, 2004.
44. Hom DB and Manivel JC: Promoting healing with recombinant human platelet-derived growth factor-BB in a previously irradiated problem wound. Laryngoscope 113: 1566-1571, 2003.
45. Robson MC, Mustoe TA and Hunt TK: The future of recombinant growth factors in wound healing. Am J Surg 176 (24 Suppl): 80S-82S, 1998.
46. Smith GN Jr, Mickler EA, Hasty KA and Brandt KD: Specificity of inhibition of matrix metalloproteinase activity by doxycycline: relationship to structure of the enzyme. Arthritis Rheum 42: 1140-1146, 1999.